| Patent | Date |
|---|
The Hsp90 Activator Aha1 Drives Production Of Pathological Tau Aggregates
App 20220241309 - Dickey; Chad ; et al. | 2022-08-04 |
Hsp90 activator Aha1 drives production of pathological tau aggregates
Grant 11,318,155 - Dickey , et al. May 3, 2 | 2022-05-03 |
Cyclophilin 40 For Reduction Of Neurotoxic Fibrils And Treatment Of Neurodegenerative Diseases
App 20210361753 - DICKEY; CHAD ; et al. | 2021-11-25 |
The Hsp90 Activator Aha1 Drives Production Of Pathological Tau Aggregates
App 20210128597 - Dickey; Chad ; et al. | 2021-05-06 |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
Grant 10,821,107 - Sabbagh , et al. November 3, 2 | 2020-11-03 |
Transgenic mouse model for conditional FKBP51 expression and related methods
Grant 10,814,015 - Dickey , et al. October 27, 2 | 2020-10-27 |
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
Grant 10,358,405 - Dickey , et al. July 23, 2 | 2019-07-23 |
Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases
App 20190218165 - Dickey; Chad ; et al. | 2019-07-18 |
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
Grant 10,287,227 - Dickey , et al. | 2019-05-14 |
Inhibitors Of The Fkbp51 Protein From A High-throughput Drug Screen And Methods Of Use
App 20180296554 - SABBAGH; JONATHAN JACOB ; et al. | 2018-10-18 |
Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases
App 20180265442 - Dickey; Chad ; et al. | 2018-09-20 |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
Grant 9,962,379 - Sabbagh , et al. May 8, 2 | 2018-05-08 |
Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases
App 20180037529 - Dickey; Chad ; et al. | 2018-02-08 |
Pharmaceutical compounds and use of same in cancer and tauopathies
Grant 9,808,448 - Gestwicki , et al. November 7, 2 | 2017-11-07 |
Pharmaceutical Compounds And Use Of Same In Cancer And Tauopathies
App 20170273963 - Gestwicki; Jason E. ; et al. | 2017-09-28 |
Transgenic Mouse Model For Conditional Fkbp51 Expression And Related Methods
App 20170258940 - Dickey; Chad ; et al. | 2017-09-14 |
Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
Grant 9,598,338 - Dickey , et al. March 21, 2 | 2017-03-21 |
Inhibitors Of The Fkbp51 Protein From A High-throughput Drug Screen And Methods Of Use
App 20170000785 - SABBAGH; JONATHAN JACOB ; et al. | 2017-01-05 |
Conversion Of Non-neuronal Cells Into Neurons
App 20170002317 - KAMATH; SIDDHARTH G. ; et al. | 2017-01-05 |
Conversion of non-neuronal cells into neurons
Grant 9,481,864 - Kamath , et al. November 1, 2 | 2016-11-01 |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
Grant 9,399,039 - Sabbagh , et al. July 26, 2 | 2016-07-26 |
Pharmaceutical Compounds And Use Of Same In Cancer And Tauopathies
App 20160000770 - Gestwicki; Jason E. ; et al. | 2016-01-07 |
Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases
Grant 9,206,103 - Dickey , et al. December 8, 2 | 2015-12-08 |
Transgenic Mouse Model For Conditional Fkbp51 Expression And Related Methods
App 20150327523 - Dickey; Chad ; et al. | 2015-11-19 |
Materials And Methods For Reduction Of Protein Tau And Treatment Of Neurodegenerative Diseases
App 20150072029 - DICKEY; Chad ; et al. | 2015-03-12 |
Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases
App 20150051294 - Dickey; Chad ; et al. | 2015-02-19 |
Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases
Grant 8,940,945 - Dickey , et al. January 27, 2 | 2015-01-27 |
Materials And Methods For Treating Neurodegenerative Diseases
App 20130209549 - Dickey; Chad | 2013-08-15 |
Materials And Methods For Reduction Of Protein Tau And Treatment Of Neurodegenerative Diseases
App 20130184353 - Dickey; Chad ; et al. | 2013-07-18 |
| 